Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.23
+0.03 (0.27%)
At close: Jun 6, 2025, 4:00 PM
11.50
+0.27 (2.43%)
After-hours: Jun 6, 2025, 7:37 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $7.63 billion as of June 6, 2025. Its market cap has decreased by -15.64% in one year.
Market Cap
7.63B
Enterprise Value
2.85B
1-Year Change
-15.64%
Ranking
Category
Stock Price
$11.23
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.63B, an increase of 1,331.30%. That is a compound annual growth rate of 80.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 7.63B | -11.35% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |